Skip to main content
Figure 2 | Journal of Inflammation

Figure 2

From: A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan

Figure 2

HA dose response of HSF gene expression. Dose response of unmodified HA (white markers) and the amide derivative of HA (black markers) on HSF expression of the indicated genes in the presence (solid line) and absence (dashed line) of IL-1β (2 ng/mL). Values are mean log fold-change from control (no IL-1 no HA; at zero) from six separate patients. Note different scales between rows. P < 0.05* different from no IL-1, no HA control; # different from IL-1, no HA control; ‡ different between the amide derivative and unmodified HA at the same concentration.

Back to article page